Compare WTBA & VALN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | WTBA | VALN |
|---|---|---|
| Founded | 1893 | 2012 |
| Country | United States | France |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 419.4M | 495.5M |
| IPO Year | 2002 | 2021 |
| Metric | WTBA | VALN |
|---|---|---|
| Price | $27.52 | $4.80 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | ★ $24.00 | $15.50 |
| AVG Volume (30 Days) | ★ 73.9K | 27.7K |
| Earning Date | 04-23-2026 | 05-07-2026 |
| Dividend Yield | ★ 4.17% | N/A |
| EPS Growth | ★ 35.21 | N/A |
| EPS | ★ 1.26 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $23.80 | N/A |
| Revenue Next Year | $9.39 | $93.87 |
| P/E Ratio | $21.58 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $17.50 | $4.75 |
| 52 Week High | $27.87 | $12.25 |
| Indicator | WTBA | VALN |
|---|---|---|
| Relative Strength Index (RSI) | 62.29 | 34.04 |
| Support Level | $22.89 | N/A |
| Resistance Level | $27.74 | $5.52 |
| Average True Range (ATR) | 0.83 | 0.14 |
| MACD | -0.03 | -0.02 |
| Stochastic Oscillator | 82.77 | 3.14 |
West Bancorp Inc is a United States-based company that offers a full range of deposit services, including checking, savings, and money market accounts and time certificates of deposit. West Bank also offers online banking, mobile banking, and treasury management services, which help to meet the banking needs of its customers. Treasury management services offered to business customers include cash management, client-generated automated clearing house transactions, remote deposit, and fraud protection services. Also offered are merchant credit card processing and corporate credit cards. The bank operates only in the United States of America.
Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.